Search research articles
Contact Us
Filters
Showing results (181-190 of 194) with videos related to
Page
of 20
Sort By:
The Veterinary Record
|
August 18, 2009
Successful treatment of a retrobulbar adenocarcinoma in a ferret (Mustela putorius furo)
M McBride, C B Mosunic, G H W Barron, et al.
Journal of Environmental Quality
|
April 28, 2011
Subsurface application of poultry litter in pasture and no-till soils
D H Pote, T R Way, P J A Kleinman, et al.
British Journal of Cancer
|
March 25, 2010
Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
D D Fang, Y J Kim, C N Lee, et al.
Blood
|
January 3, 2001
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli, O Belvedere, V Roschke, et al.
The Journal of Clinical Investigation
|
June 8, 2001
Modulation of T-cell responses to alloantigens by TR6/DcR3
J Zhang, T W Salcedo, X Wan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 8, 2000
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes
M Giovarelli, P Cappello, G Forni, et al.
Poultry Science
|
September 2, 2020
Effect of Bacillus-direct-fed microbial on leaky gut, serum peptide YY concentration, bone mineralization, and ammonia excretion in neonatal female turkey poults fed with a rye-based diet
G Tellez, M A Arreguin-Nava, J A Maguey, et al.
The Journal of Biological Chemistry
|
August 22, 2001
Interferon-kappa, a novel type I interferon expressed in human keratinocytes
D W LaFleur, B Nardelli, T Tsareva, et al.
British Journal of Cancer
|
June 11, 2008
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L M Smith, A Nesterova, M C Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors
Y J Bang, G Giaccone, S A Im, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 194) with videos related to
Sort By:
Page
of 20
The Veterinary Record
|
August 18, 2009
Successful treatment of a retrobulbar adenocarcinoma in a ferret (Mustela putorius furo)
M McBride, C B Mosunic, G H W Barron, et al.
Journal of Environmental Quality
|
April 28, 2011
Subsurface application of poultry litter in pasture and no-till soils
D H Pote, T R Way, P J A Kleinman, et al.
British Journal of Cancer
|
March 25, 2010
Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
D D Fang, Y J Kim, C N Lee, et al.
Blood
|
January 3, 2001
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli, O Belvedere, V Roschke, et al.
The Journal of Clinical Investigation
|
June 8, 2001
Modulation of T-cell responses to alloantigens by TR6/DcR3
J Zhang, T W Salcedo, X Wan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 8, 2000
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes
M Giovarelli, P Cappello, G Forni, et al.
Poultry Science
|
September 2, 2020
Effect of Bacillus-direct-fed microbial on leaky gut, serum peptide YY concentration, bone mineralization, and ammonia excretion in neonatal female turkey poults fed with a rye-based diet
G Tellez, M A Arreguin-Nava, J A Maguey, et al.
The Journal of Biological Chemistry
|
August 22, 2001
Interferon-kappa, a novel type I interferon expressed in human keratinocytes
D W LaFleur, B Nardelli, T Tsareva, et al.
British Journal of Cancer
|
June 11, 2008
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L M Smith, A Nesterova, M C Ryan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors
Y J Bang, G Giaccone, S A Im, et al.
Page
of 20